Digital Currency X Technology Finalizes Highly Dilutive $30M Private Placement

summarizeZusammenfassung

This 6-K filing details the completion of a substantial $30 million private placement, which closed in December 2025. The offering involved the sale of 23,622,047 units, each comprising one ordinary share and three warrants, at a price of $1.27 per unit. The warrant exercise price is $1.40 per share. This financing was significantly adjusted from its original terms due to a 100-for-1 reverse stock split in November 2025, which necessitated an increase in the unit purchase price to meet par value requirements. While the capital infusion provides essential working capital and general corporate funds for the company, the terms of the offering are highly dilutive, involving a substantial number of new shares and warrants issued at a significant discount to the current stock price of $4.73. This event, though providing a financial lifeline, reflects the challenging capital-raising environment for the company and will likely exert downward pressure on existing shareholder value.

check_boxSchlusselereignisse

• Closes $30 Million Private Placement

  The company completed a private placement in December 2025, raising $30 million through the sale of 23,622,047 units.

• Units Priced at Significant Discount

  Each unit, consisting of one ordinary share and three warrants, was sold at $1.27, with warrants exercisable at $1.40 per share, representing a deep discount to the current stock price of $4.73.

• Terms Adjusted Post Reverse Stock Split

  The offering's terms were revised in November 2025 following a 100-for-1 reverse stock split, which increased the par value and necessitated a higher unit price to comply with Cayman Islands law.

• Proceeds for Working Capital

  The funds raised are intended for working capital and general corporate purposes, providing a financial lifeline for the company.

auto_awesomeAnalyse

This 6-K filing details the completion of a substantial $30 million private placement, which closed in December 2025. The offering involved the sale of 23,622,047 units, each comprising one ordinary share and three warrants, at a price of $1.27 per unit. The warrant exercise price is $1.40 per share. This financing was significantly adjusted from its original terms due to a 100-for-1 reverse stock split in November 2025, which necessitated an increase in the unit purchase price to meet par value requirements. While the capital infusion provides essential working capital and general corporate funds for the company, the terms of the offering are highly dilutive, involving a substantial number of new shares and warrants issued at a significant discount to the current stock price of $4.73. This event, though providing a financial lifeline, reflects the challenging capital-raising environment for the company and will likely exert downward pressure on existing shareholder value.